Clinical Trials Browser

Phase 1/2 × Completed × ProMune × Clear all

NCT00438880 2016-02-04

Agatolimod Sodium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent or Refractory Non-Hodgkin Lymphoma

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT00031278 2011-05-30

Safety And Efficacy Study Of The Combination Of CpG 7909 And Herceptin In Patients With Metastatic Breast Cancer

Phase 1/2 Completed

12 enrolled

Tumor-Agnostic

Carcinoma, Neoplasm Metastasis, Neoplasms

NCT00043407 2009-02-12

CPG 7909 in Patients Wih Stage IV Renal Cell Cancer

Phase 1/2 Completed

42 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT00043420 2009-02-12

CPG 7909 in Patients With Cutaneous T-Cell Lymphoma

Phase 1/2 Completed

42 enrolled

DermatologicLymphoid

Lymphoma, Lymphoma, T-Cell, Cutaneous